Abstract

Viruses have evolved mechanisms of MHCI inhibition in order to evade recognition by cytotoxic CD8+ T cells (CTLs), which is well-illustrated by our prior studies on cowpox virus (CPXV) that encodes potent MHCI inhibitors. Deletion of CPXV viral MHCI inhibitors markedly attenuated in vivo infection due to effects on CTL effector function, not priming. However, the CTL response to CPXV in C57BL/6 mice is dominated by a single peptide antigen presented by H-2Kb. Here we evaluated the effect of viral MHCI inhibition on immunodominant (IDE) and subdominant epitopes (SDE) as this has not been thoroughly examined. We found that cross-priming, but not cross-dressing, is the main mechanism driving IDE and SDE CTL responses following CPXV infection. Secretion of the immunodominant antigen was not required for immunodominance. Instead, immunodominance was caused by CTL interference, known as immunodomination. Both immunodomination and cross-priming of SDEs were not affected by MHCI inhibition. SDE-specific CTLs were also capable of exerting immunodomination during primary and secondary responses, which was in part dependent on antigen abundance. Furthermore, CTL responses directed solely against SDEs protected against lethal CPXV infection, but only in the absence of the CPXV MHCI inhibitors. Thus, both SDE and IDE responses can contribute to protective immunity against poxviruses, implying that these principles apply to poxvirus-based vaccines.

Highlights

  • Strategies to leverage strong cytotoxic CD8+ T cells (CTL) responses to viral infections are of particular interest as CTLs play essential roles in controlling viral infections [1,2,3,4,5]

  • The vaccinia virus (VACV) vaccine provides cross-protection against related zoonotic orthopoxviruses, including monkey poxvirus (MXPV) and cowpox virus (CPXV), which circulate between various animal hosts and humans

  • To evade CD8+ T cells, CPXV inhibits major histocompatibility complex class I (MHCI) antigen presentation, which is required to prime CD8+ T cells

Read more

Summary

Introduction

Strategies to leverage strong cytotoxic CD8+ T cells (CTL) responses to viral infections are of particular interest as CTLs play essential roles in controlling viral infections [1,2,3,4,5]. Virus-specific CTL precursors must be primed by antigen presenting cells (APCs) that present pathogen-derived epitopes via major histocompatibility complex class I (MHCI) molecules on the cell surface. Uninfected APCs may process and cross-present exogenous antigens from infected cells. Cross-presentation is mediated primarily by Batf3-dependent CD103+/CD8α+ dendritic cells (DCs) [6,7,8], which we refer to as BATF3+ DCs. Peptide-loaded MHCI molecules from infected cells may be liberated by cell lysis or secreted in exosomes and transferred onto cross-presenting APCs. When uninfected APCs acquire preformed peptide-MHCI complexes in this manner, they are termed cross-dressed and can drive expansion of CD8+ T cells [9,10,11]. The relative contribution of these processes to non-TCR Tg CTL responses against viral antigens is largely unknown

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call